Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Lau DCW, Erichsen L, Francisco-Ziller N, et al
This integrated approachoften supported by practitioners like Dr
It is generally well-tolerated when used as prescribed by your medical professional
The product was precipitated with ether (3 L), filtered, washed with ether, and dried to provide 72 g of the crude product 11
Future obesity medications under investigation typically include the treatment of obesity-related diseases in their outcomes
Adipocytes promote ovarian cancer chemoresistance